Match the claim to the people who were studied.

Were adults like me studied?

Studies reviewed on September 28, 2026 included small trials of older adults, with 10 to 19 people in each.

Growth hormone is a chemical message made by a small gland below the brain.

In two trials, researchers tested sermorelin, made in a lab by copying part of the body’s message for growth hormone release.

The sermorelin trials lasted 14 days and 6 weeks.

The longest trial lasted 16 weeks and used a related medicine rather than sermorelin.

Body fat did not change in either the 6-week sermorelin trial or the 16-week trial of the related medicine.

Ask whether people felt or functioned better, as well as whether a hormone level in a blood test went up.

A higher number alone does not answer whether treatment would help your daily life.

Does the sleep claim hold up?

In the 16-week study of the related medicine, older adults’ sleep quality stayed the same.

That result was for the related medicine; it cannot be treated as a trial of sermorelin itself.

Ask which study supports the sleep claim attached to the product being offered.

What harms and gaps need a discussion?

A 1999 review found that the most often reported side effects were the face turning red briefly and pain where the needle went in.

Most of that research involved children, so it does not tell an adult how likely these harms are with today’s medicines made to order.

The FDA is the Food and Drug Administration, a US agency that reviews medicines.

As of September 28, 2026, sermorelin had no current FDA-reviewed prescribing information, often called a drug label.

There was no up-to-date FDA-reviewed information on how often side effects happen or on use during pregnancy.

The older studies above still provide some information about harms; the gap is in current FDA-reviewed information.

Ask the person prescribing the medicine about your health history, possible harms, follow-up and pregnancy plans if relevant.